Results 231 to 240 of about 3,040,816 (247)

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source

Empowering youth with disabilities through community-based approaches: a scoping review protocol on livelihood and social inclusion. [PDF]

BMJ Open
Maholo C, Mayat N, Lorenzo T, Naidoo N.
europepmc   +1 more source

An antisense antidote to oncogenic poison exons. [PDF]

Genes Dev
Arvola RM, Singh G.
europepmc   +1 more source

RNF213-dependent lytic destruction of <i>Chlamydia</i>-containing vacuoles activates host cell death pathways. [PDF]

Proc Natl Acad Sci U S A
Dickinson MS, Walsh SC, Bastidas RJ, Valdivia RH, Coers J.   +4 more
europepmc   +1 more source

IRB Policies on the Inclusion of Pregnant Women in Research. [PDF]

Ethics Hum Res
Morain SR, Propes C, Faden RR.
europepmc   +1 more source